
TXG Valuation
10X Genomics Inc
- Overview
- Forecast
- Valuation
- Earnings
TXG Relative Valuation
TXG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TXG is overvalued; if below, it's undervalued.
Historical Valuation
10X Genomics Inc (TXG) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.13 is considered Undervalued compared with the five-year average of -113.20. The fair price of 10X Genomics Inc (TXG) is between 25.36 to 156.30 according to relative valuation methord. Compared to the current price of 13.77 USD , 10X Genomics Inc is Undervalued By 45.72%.
Relative Value
Fair Zone
25.36-156.30
Current Price:13.77
45.72%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.76
P/B
Median3y
5.09
Median5y
11.10
3.65
FCF Yield
Median3y
-1.64
Median5y
-1.54
Competitors Valuation Multiple
The average P/S ratio for TXG's competitors is 8.64, providing a benchmark for relative valuation. 10X Genomics Inc Corp (TXG) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 9.84%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

FBNC
First Bancorp (North Carolina)
50.130
USD
+1.79%

FINV
FinVolution Group
8.940
USD
-5.10%

NEO
Neogenomics Inc
6.290
USD
-2.02%

CDLR
Cadeler A/S
22.140
USD
-0.40%

WWW
Wolverine World Wide Inc
23.240
USD
+0.04%

GLP
Global Partners LP
51.600
USD
-1.09%

STC
Stewart Information Services Corp
65.110
USD
-0.72%

SKWD
Skyward Specialty Insurance Group Inc
51.980
USD
+0.35%

IOVA
Iovance Biotherapeutics Inc
3.130
USD
-4.86%

PRDO
Perdoceo Education Corp
28.450
USD
-0.28%
FAQ

Is 10X Genomics Inc (TXG) currently overvalued or undervalued?
10X Genomics Inc (TXG) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.13 is considered Undervalued compared with the five-year average of -113.20. The fair price of 10X Genomics Inc (TXG) is between 25.36 to 156.30 according to relative valuation methord. Compared to the current price of 13.77 USD , 10X Genomics Inc is Undervalued By 45.72% .

What is 10X Genomics Inc (TXG) fair value?

How does TXG's valuation metrics compare to the industry average?

What is the current P/B ratio for 10X Genomics Inc (TXG) as of Jul 26 2025?

What is the current FCF Yield for 10X Genomics Inc (TXG) as of Jul 26 2025?

What is the current Forward P/E ratio for 10X Genomics Inc (TXG) as of Jul 26 2025?
